Page last updated: 2024-08-23

be 2254 and Adenoma, Prostatic

be 2254 has been researched along with Adenoma, Prostatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Foglar, R; Hirasawa, A; Horie, K; Shibata, K; Tsujimoto, G1

Other Studies

1 other study(ies) available for be 2254 and Adenoma, Prostatic

ArticleYear
Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy.
    European journal of pharmacology, 1995, Jan-16, Volume: 288, Issue:2

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Binding, Competitive; Cell Line; Cricetinae; DNA; Humans; Male; Phenethylamines; Plasmids; Prostatic Hyperplasia; Radioligand Assay; Rats; Recombinant Proteins; Tetralones; Transfection

1995